Search
Close this search box.

Financial results of Sanofi – Aventis Pakistan Limited for Quarter ended June 30, 2021

Karachi, Sanofi – Aventis Pakistan Limited informed Pakistan Stock Exchange about the recommendations made by the board of directors in the meeting held at Karachi on August 26, 2021.

The agenda of the meeting was discussion of profit and loss account for quarter ended June 30, 2021 which portrayed a profit of Rs. 198,113 with earnings per share 20.54 basic and diluted respectively.

Further, nil payment of cash dividend, bonus shares and right shares was agreed.

The Company was incorporated in Pakistan in 1967 as a Public Limited Company. The Company is a subsidiary of Sanofi Foreign Participations B.V., registered in Netherlands (the Parent Company). The Ultimate Parent of the Company is Sanofi S.A., France. The Company is engaged in the manufacturing and selling of pharmaceutical, consumer healthcare products and vaccines.

The total numbers of shares are 9,644,800. The Earnings per share is 51.12 in 2020 which was 16.05 in 2019. The Profit After Taxation is 493,067,000 in 2020 which was 154,836,000 in 2019.